Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes

Research output: Contribution to journalArticlepeer-review

80 Scopus citations

Fingerprint

Dive into the research topics of 'Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes'. Together they form a unique fingerprint.

Medicine & Life Sciences